Literature DB >> 28356343

Targeted deletion of Kcne3 impairs skeletal muscle function in mice.

Elizabeth C King1, Vishal Patel2, Marie Anand3,4, Xiaoli Zhao2, Shawn M Crump3,4, Zhaoyang Hu3,4, Noah Weisleder5, Geoffrey W Abbott6,4.   

Abstract

KCNE3 (MiRP2) forms heteromeric voltage-gated K+ channels with the skeletal muscle-expressed KCNC4 (Kv3.4) α subunit. KCNE3 was the first reported skeletal muscle K+ channel disease gene, but the requirement for KCNE3 in skeletal muscle has been questioned. Here, we confirmed KCNE3 transcript and protein expression in mouse skeletal muscle using Kcne3-/- tissue as a negative control. Whole-transcript microarray analysis (770,317 probes, interrogating 28,853 transcripts) findings were consistent with Kcne3 deletion increasing gastrocnemius oxidative metabolic gene expression and the proportion of type IIa fast-twitch oxidative muscle fibers, which was verified using immunofluorescence. The down-regulated transcript set overlapped with muscle unloading gene expression profiles (≥1.5-fold change; P < 0.05). Gastrocnemius K+ channel α subunit remodeling arising from Kcne3 deletion was highly specific, involving just 3 of 69 α subunit genes probed: known KCNE3 partners KCNC4 and KCNH2 (mERG) were down-regulated, and KCNK4 (TRAAK) was up-regulated (P < 0.05). Functionally, Kcne3-/- mice exhibited abnormal hind-limb clasping upon tail suspension (63% of Kcne3-/- mice ≥10-mo-old vs. 0% age-matched Kcne3+/+ littermates). Whereas 5 of 5 Kcne3+/+ mice exhibited the typical biphasic decline in contractile force with repetitive stimuli of hind-limb muscle, both in vivo and in vitro, this was absent in 6 of 6 Kcne3-/- mice tested. Finally, myoblasts isolated from Kcne3-/- mice exhibit faster-inactivating and smaller sustained outward currents than those from Kcne3+/+ mice. Thus, Kcne3 deletion impairs skeletal muscle function in mice.-King, E. C., Patel, V., Anand, M., Zhao, X., Crump, S. M., Hu, Z., Weisleder, N., Abbott, G. W. Targeted deletion of Kcne3 impairs skeletal muscle function in mice. © FASEB.

Entities:  

Keywords:  Kv3.4; MiRP2; myotonia; periodic paralysis; potassium channel

Mesh:

Substances:

Year:  2017        PMID: 28356343      PMCID: PMC5472403          DOI: 10.1096/fj.201600965RR

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  39 in total

1.  Lack of association of the potassium channel-associated peptide MiRP2-R83H variant with periodic paralysis.

Authors:  D Sternberg; N Tabti; E Fournier; B Hainque; B Fontaine
Journal:  Neurology       Date:  2003-09-23       Impact factor: 9.910

2.  The assumptions underlying the analysis of variance.

Authors:  C EISENHART
Journal:  Biometrics       Date:  1947-03       Impact factor: 2.571

3.  Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4.

Authors:  Geoffrey W Abbott
Journal:  FASEB J       Date:  2016-05-09       Impact factor: 5.191

4.  Increased store-operated Ca2+ entry in skeletal muscle with reduced calsequestrin-1 expression.

Authors:  Xiaoli Zhao; Choon Kee Min; Jae-Kyun Ko; Jerome Parness; Do Han Kim; Noah Weisleder; Jianjie Ma
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

5.  Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome.

Authors:  N M Plaster; R Tawil; M Tristani-Firouzi; S Canún; S Bendahhou; A Tsunoda; M R Donaldson; S T Iannaccone; E Brunt; R Barohn; J Clark; F Deymeer; A L George; F A Fish; A Hahn; A Nitu; C Ozdemir; P Serdaroglu; S H Subramony; G Wolfe; Y H Fu; L J Ptácek
Journal:  Cell       Date:  2001-05-18       Impact factor: 41.582

6.  Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene.

Authors:  B Fontaine; T S Khurana; E P Hoffman; G A Bruns; J L Haines; J A Trofatter; M P Hanson; J Rich; H McFarlane; D M Yasek
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

7.  Paramyotonia congenita and hyperkalemic periodic paralysis map to the same sodium-channel gene locus.

Authors:  L J Ptacek; J S Trimmer; W S Agnew; J W Roberts; J H Petajan; M Leppert
Journal:  Am J Hum Genet       Date:  1991-10       Impact factor: 11.025

8.  Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.

Authors:  Eva Delpón; Jonathan M Cordeiro; Lucía Núñez; Poul Erik Bloch Thomsen; Alejandra Guerchicoff; Guido D Pollevick; Yuesheng Wu; Jørgen K Kanters; Carsten Toftager Larsen; Jacob Hofman-Bang; Elena Burashnikov; Michael Christiansen; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-08

9.  Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness.

Authors:  Lawrence J Hayward; Joanna S Kim; Ming-Yang Lee; Hongru Zhou; Ji W Kim; Kumudini Misra; Mohammad Salajegheh; Fen-fen Wu; Chie Matsuda; Valerie Reid; Didier Cros; Eric P Hoffman; Jean-Marc Renaud; Stephen C Cannon; Robert H Brown
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

10.  Systemic ablation of RyR3 alters Ca2+ spark signaling in adult skeletal muscle.

Authors:  Noah Weisleder; Christopher Ferrante; Yutaka Hirata; Claude Collet; Yi Chu; Heping Cheng; Hiroshi Takeshima; Jianjie Ma
Journal:  Cell Calcium       Date:  2007-04-06       Impact factor: 6.817

View more
  2 in total

Review 1.  Kv Channel Ancillary Subunits: Where Do We Go from Here?

Authors:  Geoffrey W Abbott
Journal:  Physiology (Bethesda)       Date:  2022-09-01

2.  Control of Biophysical and Pharmacological Properties of Potassium Channels by Ancillary Subunits.

Authors:  Geoffrey W Abbott
Journal:  Handb Exp Pharmacol       Date:  2021
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.